We are live on ! Find out more
Qube Research & Technologies (QRT)

Qube Research & Technologies (QRT) Portfolio holdings

AUM $89.9B
1-Year Est. Return 20.22%
This Fund
S&P 500
This Quarter Est. Return
+6.9%
1 Year Est. Return
+20.22%
3 Year Est. Return
+42.42%
5 Year Est. Return
+23.97%
10 Year Est. Return
AUM
$98.4B
AUM Growth
+$12.2B
Cap. Flow
+$4.67B
Cap. Flow %
4.75%
Top 10 Hldgs %
7.81%
Holding
4,101
New
656
Increased
1,629
Reduced
1,101
Closed
596

Sector Composition

Rank Sector Weight
1 Technology 13.24%
2 Financials 10.53%
3 Industrials 10.31%
4 Healthcare 10.01%
5 Consumer Discretionary 9.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GWX icon
3501
State Street SPDR S&P International Small Cap ETF
GWX
$861M
$74 ﹤0.01%
2
TUR icon
3502
iShares MSCI Turkey ETF
TUR
$206M
$65 ﹤0.01%
2
IGE icon
3503
iShares North American Natural Resources ETF
IGE
$747M
$44 ﹤0.01%
1
ARKG icon
3504
ARK Genomic Revolution ETF
ARKG
$1.51B
$24 ﹤0.01%
1
FCG icon
3505
First Trust Natural Gas ETF
FCG
$632M
$23 ﹤0.01%
1
AAL icon
3506
American Airlines Group
AAL
$9.58B
-2,564,309
Closed -$27.5M
AAOI icon
3507
Applied Optoelectronics
AAOI
$8.04B
-99,842
Closed -$1.53M
ABX
3508
Abacus Global Management
ABX
$996M
-48,039
Closed -$360K
ABT icon
3509
Abbott
ABT
$180B
-954,788
Closed -$126M
ACR
3510
ACRES Commercial Realty
ACR
$126M
-13,404
Closed -$290K
ACWV icon
3511
iShares MSCI Global Min Vol Factor ETF
ACWV
$3.26B
-32,282
Closed -$3.76M
ADAP
3512
DELISTED
Adaptimmune Therapeutics
ADAP
-10,113
Closed -$1.99K
ADI icon
3513
Analog Devices
ADI
$181B
-969,655
Closed -$202M
ADM icon
3514
Archer Daniels Midland
ADM
$41.4B
-882,524
Closed -$42.9M
ADNT icon
3515
Adient
ADNT
$1.6B
-353,461
Closed -$4.55M
AEIS icon
3516
Advanced Energy
AEIS
$12.2B
-4,736
Closed -$451K
AGNC icon
3517
AGNC Investment
AGNC
$12.3B
-938,339
Closed -$8.4M
AGYS icon
3518
Agilysys
AGYS
$2.78B
-42,952
Closed -$3.12M
AIR icon
3519
AAR Corp
AIR
$5.15B
-53,775
Closed -$3.01M
AKRO
3520
DELISTED
Akero Therapeutics
AKRO
-150,142
Closed -$6.08M
ALC icon
3521
Alcon
ALC
$33.1B
-279,164
Closed -$25M
ALKS icon
3522
Alkermes
ALKS
$8.82B
-156,476
Closed -$5.17M
ALNY icon
3523
CALL
Alnylam Pharmaceuticals
ALNY
$36.3B
-100
Closed -$27K
ALNY icon
3524
Alnylam Pharmaceuticals
ALNY
$36.3B
-330,347
Closed -$89.2M
ALNY icon
3525
PUT
Alnylam Pharmaceuticals
ALNY
$36.3B
-100
Closed -$27K

Similar funds

Qube Research & Technologies (QRT)'s Q2 2025 Portfolio in Review

As of Q2 2025, Qube Research & Technologies (QRT) held 4,101 positions worth $98.4B, up 14% from $86.2B the previous quarter. Its ten largest holdings account for 7.8% of the portfolio.

Qube Research & Technologies (QRT) deployed $4.67B of net new capital in Q2 2025, opening 656 new positions and adding to 1,629 existing holdings. Its largest new stake was Bristol-Myers Squibb: 9,752,683 shares worth $451M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 15% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $675M trimmed.

  • Qube Research & Technologies (QRT)'s largest Q2 2025 buy was Bristol-Myers Squibb: 9,752,683 shares worth $451M.
  • Qube Research & Technologies (QRT) added most to Thermo Fisher Scientific in Q2 2025, an estimated $486M increase.
  • Qube Research & Technologies (QRT)'s biggest Q2 2025 reduction was Meta Platforms (Facebook), cutting an estimated $675M.
  • Qube Research & Technologies (QRT) fully exited Broadcom in Q2 2025, selling an estimated $1.02B.
  • Qube Research & Technologies (QRT)'s ten largest holdings make up 7.8% of its $98.4B portfolio in Q2 2025.
  • Qube Research & Technologies (QRT) opened 656 new positions and closed 596 in Q2 2025.
  • Qube Research & Technologies (QRT)'s portfolio value rose 14% quarter-over-quarter to $98.4B.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2025, filed 14 Aug 2025.